BlockBeats News, August 23 — U.S.-listed Ethereum reserve company ETHZilla (formerly 180 Life Sciences) announced that, according to a sales agreement signed and amended with Clear Street LLC, the company plans to periodically issue and sell common stock through Clear Street as its sales agent, with a maximum total fundraising amount of up to $10 billion.
As of this announcement, the company has issued and sold 5,001,310 shares of common stock under the original sales agreement, raising a total of approximately $34.4 million. From the date of this supplemental prospectus, the company will no longer sell common stock pursuant to the at-the-market offering prospectus filed on August 13, 2025.